Clinical utility of monitoring serum cryptococcal antigen (sCRAG) titers in patients with AIDS

HIV Clinical Trials

Volumn 1, Issue 1, 2000, Pages 1-6

  Aberg, Judith A ^a   Watson, Jessica ^b   Segal, Mark ^c   Chang, Larry W ^d  

^a SAN FRANCISCO GENERAL HOSPITAL   (United States)

^b UNIVERSITY OF CALIFORNIA   (United States)

^c EMORY UNIVERSITY SCHOOL OF MEDICINE   (United States)

^d WASHINGTON UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

AIDS; C yptococcos s; Cryptococcal antiqen; HIV

Indexed keywords

EID: 33746687043     PISSN: 15284336     EISSN: None     Source Type: Journal    
DOI: 10.1310/NQXR-ULMG-MM1B-3T2B     Document Type: Article

References (9)

1. Hajjeh RA, Conn LA, Stephens DS, et al. Cryptococcosis: Population-based multistate active surveillance and risk factors in human immunodeficiency virus-infected persons. Cryptococcal Active Surveillance Group. J Infect Dis. 1999:179:449-454.
2. Feldmesser M, Harris C, Reichberg S, Khan S, Casadevall A. Serum cryptococcal antigen in patients with AIDS. Clin InfectDis. 1996:23:827-830.
3. Currie BP, Freundlich LF, Soto MA, Casadevall A. Falsenegative cerebrospinal fluid cryptococcal latex agglutination tests for patients with culture-positive cryptococcal meningitis. J Clin Microblol. 1993;31:2519-2522.
4. Tanner DC, Weinstein MP, Fedorciw B, et al. Comparison of commercial kits for detection of cryptococcal antigen. J Clin Microblol. 1994;32:1680-1684.
5. Shahab ST, Habte-Gabr E, Fedorko D. Significance of cryptococcal antigen titers in patients with AIDS. South MedJ. 1991:84:1407-1408.
6. Powderly WG, Cloud GA, Dismukes WE, Saag MS. Measurement of cryptococcal antigen in serum and cerebrospinal fluid: Value in the management of AIDS-associated cryptococcal meningitis. Clin Infect Dis. 1994;18:789-792.
7. Saag MS, Cloud GA, Graybill R, et al. A comparison of itraconazole versus fluconazole as maintenance therapy for AIDS-associated cryptococcal meningitis. Clin Infect Dis. 1999:28:291-296.
8. Robinson PA, Bauer M, Leal MAE, et al. Early mycological treatment failure in AIDS-associated cryptococcal meningitis. Clin Infect Dis. 1999:28:82-92.
9. Collett D. Modelling Survival Data in Medical Research. London: Chapman & Hall Publishers; 1994. 10. Tuazon CU, Powderly WG, Cloud GA, et al. Utility of serum and CSF cryptococcal antigen in the management of cryptococcal meningitis in AIDS patients. Presented at: 36th Annual Meeting of the Infectious Disease Society of America; November 1998; Denver, CO. 334.